Client News

invIOs goes live with unique cell therapy platform and clinical-stage immuno-oncology pipeline

Patronus Health GmbH Receives Angel Investment and Public Grant

sterna biologicals announces dosing of first patient in phase IIa proof-of-concept study with SB010 in moderate to severe asthma

Marinomed and Friedrich-Alexander-Universität Erlangen-Nürnberg publish new data on antiviral efficacy of iota-carrageenan against SARS-CoV-2 variants of concern

Apogenix Receives EUR 20.7 Million in Public Funding for Pivotal Study and Preparation for Market Production of Asunercept for the Treatment of COVID-19

RedHill Biopharma Reports that Opaganib Mechanism Not Impacted by Viral Spike-Protein Mutations, Including Omicron Mutations

Atriva Therapeutics strengthens advisory board with Piet Wigerinck

Newron Pharmaceuticals S.p.A.: Change in Newron Board of Directors

Abivax receives FDA feedback with guidance on advancing ABX464 into phase 3 clinical testing in ulcerative colitis

Marinomed to present at Munich capital market conference (MKK)